The national biotechnology strategy was published in 2001. The process followed for drafting the strategy is as follows: involvement of experts; wider consultation with stakeholders and adoption and publication. The mandate for the BRICs was to focus on: commercialising biotechnology innovations coming out of universities, research councils, private sector; to focus on three focus areas of human health, bioprocessing, focus on animal health; plant biotechnology for PlantBio; to establish a national bioinformatics capacity to serve the biotechnology innovation needs (NBN) and to Build research-industry linkages
Reference:
Msomi, N. Impact of the national biotechnology strategy on the South African biopharma industry. Science Real and Relevant: 2nd CSIR Biennial Conference, CSIR International Convention Centre Pretoria, 17 & 18 November 2008, pp 13
Msomi, N. (2008). Impact of the national biotechnology strategy on the South African biopharma industry. CSIR. http://hdl.handle.net/10204/3248
Msomi, N. "Impact of the national biotechnology strategy on the South African biopharma industry." (2008): http://hdl.handle.net/10204/3248
Msomi N, Impact of the national biotechnology strategy on the South African biopharma industry; CSIR; 2008. http://hdl.handle.net/10204/3248 .